Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.13). Revenue for the quarter came in at $9.1 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Citi reiterates Buy rating on AMD with $575 price target post TMT conference
• Mizuho Defends Sarepta Therapeutics (SRPT)